OxySure Systems, Inc. (OXYS) Launches OxySure Commercial Finance

Frisco, TX -- (Marketwired – October 15, 2013) - OxySure Systems, Inc. (OTCQB: OXYS) (“OxySure” or the “Company”), a medical technology company that has pioneered an FDA-approved solution to produce medically pure oxygen from dry, inert powders for emergency and short duration use, today announced the launch of OxySure Commercial FinanceSM , a service that allows OxySure customers to easily and conveniently lease OxySure’s suite of medical devices and products, including the OxySure Model 615, Automated External Defibrillators (AEDs), and other medical equipment, supplies and accessories.PDF Version

 

Powered by LeaseQ, OxySure Commercial FinanceSM allows customers to do comparison shopping for lease quotes from dozens of third party lenders with one simple online form that takes two minutes to complete. The system can pre-qualify customers instantly and display the top results, allowing customers to select from multiple, pre-qualified offers. The system also provides customers the flexibility to select lenders of choice and payment plan characteristics such as monthly payment, finance term and terminal value. 

 

Julian T. Ross, CEO of OxySure, stated, “We are excited about the OxySure Commercial FinanceSM program because the program makes it easy to differentiate OxySure sales with financing options wherever OxySure products are sold. By offering our customers the opportunity of an attractive monthly cost via third party financing, OxySure products and solutions become significantly more affordable. The program can also facilitate or fast track the purchasing process and can typically provide tax advantages to corporate buyers.” 

 

OxySure Commercial FinanceSM is not a direct lender but has partnered with the leading finance companies in the marketplace to provide competitive rates across a large spectrum of financial needs. OxySure Commercial FinanceSM is a private label solution of the innovative LeaseQ platform, and quotes and other information can be found by visiting the following link: http://www.oxysure.com/aed/index.php/lease-financing

About OxySure Systems, Inc.

OxySure Systems, Inc. (OTCQB : OXYS) is a medical technology company that focuses on the design, manufacture and distribution of specialty respiratory and medical solutions. The company pioneered a safe and easy to use solution to produce medically pure (USP) oxygen from inert powders. The company owns numerous issued patents and patents pending on this technology which makes the provision of emergency oxygen safer, more accessible and easier to use than traditional oxygen provision systems. OxySure’s products improve access to emergency oxygen that affects the survival, recovery and safety of individuals in several areas of need: (1) Public and private places and settings where medical emergencies can occur; (2) Individuals at risk for cardiac, respiratory or general medical distress needing immediate help prior to emergency medical care arrival; and (3) Those requiring immediate protection and escape from exposure situations or oxygen-deficient situations in industrial, mining, military, or other “Immediately Dangerous to Life or Health” (IDLH) environments. www.OxySure.com

 

Forward-Looking Statements

This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements contained in this release that are not historical facts, including, without limitation, statements that relate to the Company's expectations with regard to the future impact on the Company's results from new products in development, may be deemed to be forward-looking statements. Words such as "expects", "intends", "plans", "may", "could", "should", "anticipates", "likely", "believes" and words of similar import also identify forward-looking statements. These statements are subject to risks and uncertainties. Forward-looking statements are based on current facts and analyses and other information that are based on forecasts of future results, estimates of amounts not yet determined and assumptions of management. Readers are urged not to place undue reliance on the forward-looking statements, which speak only as of the date of this release. Except as may be required under applicable law, we assume no obligation to update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this release. Additional information on risks and other factors that may affect the business and financial results of OxySure Systems, Inc. can be found in the filings of OxySure Systems, Inc. with the U.S. Securities and Exchange Commission.

DreamTeamGroup

Indianapolis, IN 

www.DTG.fm 

317-623-3050 

This email address is being protected from spambots. You need JavaScript enabled to view it.

 

Barwicki Investor Relations

Andrew Barwicki

President

516-662-9461

This email address is being protected from spambots. You need JavaScript enabled to view it.